RhumbLine Advisers
BIIB icon

RhumbLine Advisers’s Biogen BIIB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$37.7M Buy
300,147
+3,853
+1% +$484K 0.03% 457
2025
Q1
$40.5M Buy
296,294
+27,703
+10% +$3.79M 0.04% 407
2024
Q4
$41.1M Sell
268,591
-5,718
-2% -$874K 0.04% 398
2024
Q3
$53.2M Sell
274,309
-9,897
-3% -$1.92M 0.05% 325
2024
Q2
$65.9M Buy
284,206
+5,562
+2% +$1.29M 0.06% 261
2024
Q1
$60.1M Buy
278,644
+597
+0.2% +$129K 0.06% 288
2023
Q4
$72M Sell
278,047
-505
-0.2% -$131K 0.08% 231
2023
Q3
$71.6M Sell
278,552
-2,184
-0.8% -$561K 0.08% 211
2023
Q2
$80M Buy
280,736
+956
+0.3% +$272K 0.09% 198
2023
Q1
$77.8M Buy
279,780
+1,175
+0.4% +$327K 0.1% 193
2022
Q4
$77.2M Buy
278,605
+5,359
+2% +$1.48M 0.1% 181
2022
Q3
$73M Buy
273,246
+10,082
+4% +$2.69M 0.11% 167
2022
Q2
$53.7M Buy
263,164
+12,204
+5% +$2.49M 0.08% 231
2022
Q1
$52.9M Sell
250,960
-22,739
-8% -$4.79M 0.07% 254
2021
Q4
$65.7M Buy
273,699
+4,266
+2% +$1.02M 0.08% 214
2021
Q3
$76.2M Sell
269,433
-4,906
-2% -$1.39M 0.1% 170
2021
Q2
$95M Sell
274,339
-19,578
-7% -$6.78M 0.12% 142
2021
Q1
$82.2M Sell
293,917
-15,559
-5% -$4.35M 0.11% 151
2020
Q4
$75.8M Sell
309,476
-43,308
-12% -$10.6M 0.1% 159
2020
Q3
$100M Sell
352,784
-4,405
-1% -$1.25M 0.16% 125
2020
Q2
$95.6M Buy
357,189
+1,672
+0.5% +$447K 0.16% 123
2020
Q1
$112M Buy
355,517
+3,818
+1% +$1.21M 0.24% 83
2019
Q4
$104M Sell
351,699
-2,052
-0.6% -$609K 0.17% 112
2019
Q3
$82.4M Sell
353,751
-3,282
-0.9% -$764K 0.15% 138
2019
Q2
$83.5M Buy
357,033
+20,925
+6% +$4.89M 0.16% 123
2019
Q1
$79.4M Buy
336,108
+11,441
+4% +$2.7M 0.15% 125
2018
Q4
$97.7M Sell
324,667
-1,464
-0.4% -$441K 0.21% 88
2018
Q3
$115M Sell
326,131
-19,129
-6% -$6.76M 0.22% 84
2018
Q2
$100M Buy
345,260
+5,754
+2% +$1.67M 0.2% 94
2018
Q1
$93M Sell
339,506
-6,966
-2% -$1.91M 0.19% 103
2017
Q4
$110M Buy
346,472
+7,395
+2% +$2.36M 0.22% 90
2017
Q3
$106M Buy
339,077
+3,821
+1% +$1.2M 0.23% 85
2017
Q2
$91M Sell
335,256
-3,376
-1% -$916K 0.21% 96
2017
Q1
$92.6M Sell
338,632
-29,033
-8% -$7.94M 0.22% 90
2016
Q4
$104M Buy
367,665
+10,301
+3% +$2.92M 0.26% 70
2016
Q3
$112M Buy
357,364
+8,533
+2% +$2.67M 0.31% 61
2016
Q2
$84.4M Buy
348,831
+14,612
+4% +$3.53M 0.25% 78
2016
Q1
$87M Buy
334,219
+8,921
+3% +$2.32M 0.27% 70
2015
Q4
$99.7M Sell
325,298
-11,589
-3% -$3.55M 0.32% 59
2015
Q3
$98.3M Buy
336,887
+2,454
+0.7% +$716K 0.33% 58
2015
Q2
$135M Sell
334,433
-56,632
-14% -$22.9M 0.43% 43
2015
Q1
$165M Sell
391,065
-6,863
-2% -$2.9M 0.48% 40
2014
Q4
$135M Sell
397,928
-7,139
-2% -$2.42M 0.39% 50
2014
Q3
$134M Sell
405,067
-2,242
-0.6% -$742K 0.4% 46
2014
Q2
$128M Sell
407,309
-18,878
-4% -$5.95M 0.38% 48
2014
Q1
$130M Sell
426,187
-7,829
-2% -$2.39M 0.39% 50
2013
Q4
$121M Sell
434,016
-10,460
-2% -$2.93M 0.36% 55
2013
Q3
$107M Sell
444,476
-8,124
-2% -$1.96M 0.33% 60
2013
Q2
$97.4M Buy
+452,600
New +$97.4M 0.31% 61